What I get is La Roche-Posay
Anthelios UVmune 400 Invisible Fluid. The American version doesn't protect as much against UVA because the new fancy filters haven't been approved by the FDA yet.
A great choice, my favorite for daily wear, but Anthelios is basically sold everywhere over here.
I have no dog in this fight, especially because as someone who often finds themselves defending EU regulations to people who grew up in the States, but I have a hard time following why the FDA appears to drag their heels on approving more advanced filters, whilst Australian, South Korean and EU regulators are all far quicker. Do these three major jurisdictions with historically the highest standards for sunscreens have more streamlined processes, are they willing to take more risks, is the FDA simply underfunded to handle throughput?
It's especially odd considering other parts of FDA approval can often feel overly fast compared to other the regulators jurisdictions, especially when it comes to approving medical devices[0].
